Search

Welcome to NRG Oncology!

Welcome to the NRG Oncology Web site! This resource serves to provide current information about NRG Oncology’s exciting research future and the latest updates about plans to support our clinical trial endeavors. We invite you to check back often to learn “what’s new.”

Who We Are

NRG Oncology brings together the unique and complementary research areas of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). NRG Oncology builds upon our more than 150 years of cumulative research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer. NRG Oncology has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).

 

NCORP

Learn about the leaders and plans for NRG Oncology's NCORP Research Base.

 

NRG Oncology
Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103
267-519-6630
Contact Us

To receive the NRG Oncology Newsletter and occasional eNews announcements and press releases, please click on the link to complete the request form.

Powered by Benchmark Email

What’s New

Dr. George named chair of NRG Oncology Colorectal Cancer Committee.

NRG RTOG 9802 shows increased survival for low-grade glial brain tumors in NEJM publication.  Read more 

NRG RTOG 0415 reports benefit of shortened RT schedule for low-risk prostate cancer patients.  Read more 

Dr. Wolmark's SABCS presentation available to view online. Read more

Dr. Ganz to receive ASCO's Inaugural Joseph V. Simone Award and Lecture.  Read more

Referral of Patients with pleuropulmonary blastoma (PPB) and PPB-associated tumors (cystic nephroma, Sertoli-Leydig cell tumors and other sex dord-stromal tumors).  Read more

Dr. Wolmark to receive McGuire Memorial Lectureship award at SABCS.  Read more

Twenty-three NRG Oncology presentations were featured at ASTRO 2015 including two plenary session presentations. Read more 

Walter J. Curran, Jr., MD, an NRG Oncology Chair and one of Jimmy Carter's treating physicians at the Winship Cancer Institute of Emory University, was interviewed for the article "Treating Jimmy Carter's Cancer" that appeared in the August 24 edition of The Atlantic Journal-Constitution. Link to article

NRG Oncology Science at the 2015 ASCO Annual Meeting

Postmenopausal women treated for ductal carcinoma in situ breast cancer gain significant benefit from treatment with anastrazole compared with tamoxifen. Read more

Patients with prostate  cancer at high risk for metastasis live longer when chemotherapy is added to the standard treatment regimen of radiotherapy and hormonal therapy. Read more

Trial results evaluating the addition of bevacizumab to paclitaxel/carboplatin chemotherapy support further investigation of anti-angiogenesis targeting agents in endometrial cancer. Read more

 











Copyright 2016 by NRG Oncology